Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis.

Zonder JA, Barlogie B, Durie BG, McCoy J, Crowley J, Hussein MA.

Blood. 2006 Jul 1;108(1):403; author reply 404. No abstract available.

2.

Aspirin as thromboprophylaxis in myeloma.

Niesvizky R, Martínez-Baños DM.

Leuk Lymphoma. 2008 Aug;49(8):1646-7. doi: 10.1080/10428190802199978. No abstract available.

PMID:
18766978
3.

Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone.

Klein U, Kosely F, Hillengass J, Hundemer M, Schmitt S, Neben K, Moehler T, Hegenbart U, Ho AD, Goldschmidt H.

Ann Hematol. 2009 Jan;88(1):67-71. doi: 10.1007/s00277-008-0561-1. Epub 2008 Jul 31.

PMID:
18668241
4.

Thalidomide in front line treatment in multiple myeloma: serious risk of venous thromboembolism and evidence for thromboprophylaxis.

Rus C, Bazzan M, Palumbo A, Bringhen S, Boccadoro M.

J Thromb Haemost. 2004 Nov;2(11):2063-5. No abstract available.

5.

Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma.

Niesvizky R, Martínez-Baños D, Jalbrzikowski J, Christos P, Furst J, De Sancho M, Mark T, Pearse R, Mazumdar M, Zafar F, Pekle K, Leonard J, Jayabalan D, Coleman M.

Leuk Lymphoma. 2007 Dec;48(12):2330-7.

PMID:
18067007
6.

Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide.

Palumbo A, Rus C, Zeldis JB, Rodeghiero F, Boccadoro M; Italian Multiple Myeloma Network, Gimema.

J Thromb Haemost. 2006 Aug;4(8):1842-5. No abstract available.

7.

Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure.

Wang M, Dimopoulos MA, Chen C, Cibeira MT, Attal M, Spencer A, Rajkumar SV, Yu Z, Olesnyckyj M, Zeldis JB, Knight RD, Weber DM.

Blood. 2008 Dec 1;112(12):4445-51. doi: 10.1182/blood-2008-02-141614. Epub 2008 Sep 17.

8.

Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.

Huston A, Brown J, Roodman GD.

Exp Hematol. 2006 Dec;34(12):1616. No abstract available.

PMID:
17157156
9.

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.

Palumbo A, Rajkumar SV, Dimopoulos MA, Richardson PG, San Miguel J, Barlogie B, Harousseau J, Zonder JA, Cavo M, Zangari M, Attal M, Belch A, Knop S, Joshua D, Sezer O, Ludwig H, Vesole D, Bladé J, Kyle R, Westin J, Weber D, Bringhen S, Niesvizky R, Waage A, von Lilienfeld-Toal M, Lonial S, Morgan GJ, Orlowski RZ, Shimizu K, Anderson KC, Boccadoro M, Durie BG, Sonneveld P, Hussein MA; International Myeloma Working Group.

Leukemia. 2008 Feb;22(2):414-23. Epub 2007 Dec 20. Review.

PMID:
18094721
10.

Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.

Palumbo A, Cavo M, Bringhen S, Zamagni E, Romano A, Patriarca F, Rossi D, Gentilini F, Crippa C, Galli M, Nozzoli C, Ria R, Marasca R, Montefusco V, Baldini L, Elice F, Callea V, Pulini S, Carella AM, Zambello R, Benevolo G, Magarotto V, Tacchetti P, Pescosta N, Cellini C, Polloni C, Evangelista A, Caravita T, Morabito F, Offidani M, Tosi P, Boccadoro M.

J Clin Oncol. 2011 Mar 10;29(8):986-93. doi: 10.1200/JCO.2010.31.6844. Epub 2011 Jan 31.

PMID:
21282540
11.

Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma.

Palumbo A, Dimopoulos M, San Miguel J, Harousseau JL, Attal M, Hussein M, Knop S, Ludwig H, von Lilienfeld-Toal M, Sonneveld P.

Blood Rev. 2009 Mar;23(2):87-93. doi: 10.1016/j.blre.2008.07.003. Epub 2008 Sep 6. Review.

PMID:
18774632
12.

Lenalidomide in myelodysplastic syndrome and multiple myeloma.

Shah SR, Tran TM.

Drugs. 2007;67(13):1869-81. Review.

PMID:
17722955
13.

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.

Larocca A, Cavallo F, Bringhen S, Di Raimondo F, Falanga A, Evangelista A, Cavalli M, Stanevsky A, Corradini P, Pezzatti S, Patriarca F, Cavo M, Peccatori J, Catalano L, Carella AM, Cafro AM, Siniscalchi A, Crippa C, Petrucci MT, Yehuda DB, Beggiato E, Di Toritto TC, Boccadoro M, Nagler A, Palumbo A.

Blood. 2012 Jan 26;119(4):933-9; quiz 1093. doi: 10.1182/blood-2011-03-344333. Epub 2011 Aug 11.

14.

Thromboembolism with immunomodulatory agents in the treatment of multiple myeloma.

Singh A, Gajra A.

Cardiovasc Hematol Agents Med Chem. 2011 Jan;9(1):7-13. Review.

PMID:
20874693
15.

Thrombosis in multiple myeloma.

Zangari M, Elice F, Fink L, Tricot G.

Expert Rev Anticancer Ther. 2007 Mar;7(3):307-15. Review.

PMID:
17338651
16.

Lenalidomide and its role in the management of multiple myeloma.

Falco P, Cavallo F, Larocca A, Liberati AM, Musto P, Boccadoro M, Palumbo A.

Expert Rev Anticancer Ther. 2008 Jun;8(6):865-74. doi: 10.1586/14737140.8.6.865. Review.

PMID:
18533796
17.

Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis.

Zamagni E, Brioli A, Tacchetti P, Zannetti B, Pantani L, Cavo M.

Semin Thromb Hemost. 2011 Apr;37(3):209-19. doi: 10.1055/s-0031-1273085. Epub 2011 Mar 31.

PMID:
21455855
18.

Tailored thromboprophylaxis for patients with multiple myeloma treated by IMIDs.

Paydas S.

Leuk Lymphoma. 2008 Aug;49(8):1644-5. doi: 10.1080/10428190802187155. No abstract available.

PMID:
18766977
19.

Anticoagulation regimens for thalidomide and lenalidomide.

Zangari M.

Clin Adv Hematol Oncol. 2006 Sep;4(9):658-9. No abstract available.

PMID:
17099621
20.

Lenalidomide in combination with dexamethasone for the treatment of multiple myeloma after one prior therapy.

Hazarika M, Rock E, Williams G, Dagher R, Sridhara R, Booth B, Farrell A, Justice R, Pazdur R.

Oncologist. 2008 Oct;13(10):1120-7. doi: 10.1634/theoncologist.2008-0077. Epub 2008 Oct 15.

Supplemental Content

Support Center